Furthermore, upregulation of SLC25A5 has been associated with better overall survival in patients with colon cancer.(40) Our findings support the evidence that upregulated SLC25 family members play an important role in cancer management, as observed exclusively in R patients. Here, SLC25A5 is linked to malignant colon neoplasm.